PHCbi brand pharmaceutical refrigerators and biomedical freezers offer a comprehensive selection of storage solutions for high-value vaccines and other biologics. These cabinets are based on high performance refrigeration platforms engineered for reliability, temperature uniformity, fast temperature recovery and tolerance for real-world conditions.
Solutions for the Cold Chain Spectrum
Vaccines developed in response to the COVID-19 pandemic require a wider range of cold chain storage temperatures, with some requiring multiple storage temperature points from delivery to administration. PHCbi brand offers a wide range of ultra-low temperature freezers, pharmaceutical refrigerators and combination refrigerator and freezer units that help you safely store any COVID-19 vaccine in addition to other pharmaceutical products.
Safe Vaccine Storage Begins with Product Selection
PHCbi pharmaceutical refrigerators and freezers satisfy any storage protocol or space requirement. Robust refrigeration systems and cabinet designs assure temperature uniformity, reliability and energy efficiency. All are engineered to maintain required temperatures for product viability and to achieve rapid temperature recovery after multiple door openings.

Ultra-Low Temperature Freezers, -60°C to -80°C
Ultra-low temperature freezers are required for storage of mRNA, viral vector and non-replicating viral vector vaccines. Other applications include short and long-term storage of clinical specimens.

Biomedical Freezers, -40°C
For vaccine development and storage of enzymes and other biomaterials according to manufacturers' inserts or directives.

Biomedical Freezers, -20°C
For intermediate term storage of emerging vaccines, feedstocks, and other biomaterials according to manufacturers' inserts or directives.

Biomedical Refrigerator/Freezer Combo, 2°C to 8°C, and -20°C
Space-saving cabinets designed for both refrigerator and freezer functions in the same footprint. Refrigerator and freezer systems are independent for maximum stored product safety.

Pharmaceutical Refrigerators, 2°C to 8°C
For short-term storage of vaccines days prior to administration.
PHC Corporation of North America (PHCNA), headquartered in Wood Dale, IL, is a supplier of PHCbi life science laboratory solutions. PHCNA empowers scientific advancement by providing technologies that protect and support critical research. PHCbi solutions provided by PHCNA are trusted by researchers across the United States, Canada, and select countries in Latin America for their reliability and innovation.
PHCbi is a global leader in life science laboratory equipment, offering solutions that enhance every stage of the research workflow — from sample preservation to cell culture to regenerative medicine.
PHCNA is a proud subsidiary of PHC Holdings Corporation (TSE 6523), based in Tokyo, Japan — a global healthcare enterprise that develops, manufacturers, distributes, and services solutions across diabetes management, healthcare solutions, diagnostics and life sciences.
1 A 2012 Centers for Disease Control and Prevention (CDC) report revealed improper storage of some vaccines from the Vaccines for Children (VFC) program serving an estimated 40 million children through a national network.
2 NSF International (NSF) and The U.S. Center for Disease Control and Prevention have assigned industry consultants comprised of leading refrigeration and freezer cabinet manufacturers, including PHC Corporation of North America, to establish vaccine storage guidelines with an emphasis on establishing criteria for storage refrigerators to protect refrigerated vaccines from freezing. These criteria will require that all vaccines be stored in refrigerators that meet performance standards currently offered by PHC.
4 U.S. National Institute of Standards and Technology. (2009).
Thermal analysis of refrigeration systems used for vaccine storage. Gaithersburg, MD: Chojnacky, M., Miller, W., Ripple, D., & Strouse, G. Retrieved from
http://www.nist.gov/customcf/get_pdf.cfm?pub_id=904574